Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients

Neoplasm development in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs) has been widely discussed. The aim of this work is to determine neoplasm frequency, relationship with the prescription pattern of DMTs, and influence of the patients’ baseline characteristics. Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil-Bernal, Rosalía, González-Caballero, Juan Luis, Espinosa-Rosso, Raúl, Gómez-Gómez, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206070/
https://www.ncbi.nlm.nih.gov/pubmed/34131191
http://dx.doi.org/10.1038/s41598-021-91912-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206070/
https://www.ncbi.nlm.nih.gov/pubmed/34131191
http://dx.doi.org/10.1038/s41598-021-91912-x

Ejemplares similares